Non-Viral Gene Therapies Get €51M Boost, Though Challenges Remain
Although most gene therapy still relies on non-infectious viral vectors for delivery, a recent venture…
As one of the biggest success stories of the 21st century, gene therapy is providing hope for treating diseases that once seemed incurable. Any genetic mutation causing disease could theoretically be fixed by inserting a new copy of the faulty gene. This means that gene therapy has the potential to treat some previously incurable conditions with a single dose.
By 2025, the FDA expects to approve between 10 and 20 gene therapies each year, and we are already seeing an increase in the number of approvals today. However, the field continues to face a number of obstacles ranging from safety concerns to manufacturing shortages. Read on to get the latest in the gene therapy field.
Gene Therapy Industry Report 2021
In this report, we take a closer look at the growing gene therapy market, current development and manufacturing challenges, and the exciting future ahead for this industry.
Go to ReportAlthough most gene therapy still relies on non-infectious viral vectors for delivery, a recent venture…
The French investor Sofinnova Partners has injected a total of €6M into three Italian gene…
While oncology and psychedelics dominated European biotech’s biggest funding rounds last month, startup seed financing…
Stock markets worldwide have experienced painful instability in the last few months. As a result,…
Last month, the US firm bluebird bio abandoned the sale of its gene therapy Zynteglo…
The rise of adenoviral Covid-19 vaccines highlights the potential of companies using similar technology in…
Since the approval of the first gene therapy for blindness, there has been a wave…
Gene therapy has traditionally been applied to well-understood diseases where a single genetic mutation was…
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled…
Taking advantage of the ability of viruses to manipulate life is opening new doors for…
Gene therapy is a hot area in the biotech industry right now, with many treatments…
This week, German big pharma Bayer announced a €3.5B takeover of Asklepios BioPharmaceutical, a well…